If there is a company whose only job is to file EU applications... IMO, it's a plus that ADXS hired em to file for EU Approval...

So many companies mentioned in the article and ADXS nowhere in sight :(

"Over the next decade, immunotherapies will be the backbone of cancer treatments in 60% of cancer types. It is forecast that by 2020, Avastin, Nivolumab, Revlimid, Rituxan and Xtandi will be the top five cancer drugs."

Source:
https://www.barchart.com/story/stocks/quotes/BGNE/5102163/global-80-billion-cancer-immunotherapy-market-to-2022

Joe,
The article states that patent approval is pending. Approximately when do you think we should hear on patent approval?

"In June, the company filed a patent application for its active cannabinoid-based topical cream. The patent application if approved should accelerate the ongoing discussions and negotiations regarding scientific and medical collaboration."

Source:
https://insiderfinancial.com/owc-pharmaceutical-research-corp-otcmktsowcp-gigantic-move-signals-buy-opportunity/174272/

Time for ADXS to break some technical chart barriers of mid $3s... then we fly!

For ADRO: H.C. Wainwright & Co. cuts PT to $9.50 from $18

It will be in interesting day for both ADXS & ADRO

ADXS P/S ratio is 8.76 VS. Biotech Industry P/S ratio is 113.99. Translation: ADXS can be $20+ and be still considered undervalued!

ADRO +$0.45 right now

ADXS red right now

"Yvonne Patterson has reiterated the differences numerous times as she created both strains in her lab. The differences are striking and she pointed these out last at one of the analyst investor conferences a couple of years ago. She threw the strain ADURO is using in the trash because it wasn’t very versatile and couldn’t be given in large dose without toxicity."

For discussion purposes: then why does ADRO continue to use the bad LM strain, and why are big investors backing ADRO instead of ADXS?

Dew,
Is ADRO's "attenuated double-deleted Listeria monocytogenes (pLADD) " different from ADXS LM?

So nothing science related fall? If so I may open a new position... what do you think?

Anyone know why AVXL is dropping hard today? Is that a good buying opportunity?

I don't own AVXL, but a lot people on this board do...

IMO, The problem is that ADXS lacks new buyers both retail and tutes.... otherwise the cartel couldn't have controlled it for so many years....

We just need new buyers, and the sad part is no new buyers at this ridiculously low $3 price...

Which leads to another assumption is that new buyers don't know/understand ADXS science and its potential... it takes some time to absorb... but then they should look at AMGEN & SELLAS deal approximating $1 billion in partnership money....

WHY CAN'T THE MARKET SEE WHAT WE SEE?

I stopped visiting Yahoo after they changed the message board to that ugly format...

IMO yahoo isn't getting as much care after it's sale to Verizon...

"Only $212 difference in pps" BLUE vs ADXS

ADXS should atleast be 10 percent of that difference ($21.20) on the lowball.... yet realty is that ADXS is about 1.5 percent ($3)

WTF IS THIS NONE SENSE...

Biotech Index higher premarket, expecting ADXS to break $3 first thing on open....

And the thing I don't understand.... there are biotechs that shoot thru the roof on mediocre updates,

And then there is ADXS that goes red on 99% of the positive new updates....

Thanks for the post gbrown, good work!

ADXS: No institutional sell or buy since 11/20/17 per link below:

https://fintel.io/so/us/adxs


What do you guys think?

Value of Manufacturing Facility: you are all correct, except there is a misunderstanding in explanation:

1. The manufacturing facility is a rental and in physical pieces, it's not worth a lot.. maybe 10 million to 20 million

2. Blue is looking at the factory as a whole and what it's producing. Now that right can't be given for 10 mill or 20 mill... that has got to be well over 200 mill

It is stated in the quarterly reports to SEC... right now, since ADXS isn't making money, rent is very cheap for like the first five years....

It's like a win win for both landlords and ADXS... have very long leases, start very low and then jack up as company becomes successful

I agree with Gantor, all of ADXS property including manufacturing facility is a rental....

And then rent goes up like 5 times in year 2022... so phase 3 must work or just the rent will be eating a lot of money

"If you can see this, why can't Adage, Fidelity, and other institutional investors? Why aren't they buying if this is such an incredible deal?"

Because their agenda is to keep ADXS lower IMO

Anyone know if DOC is still holding ADXS shares or sold some or most out?

ADRO seemed to have insider sellout in mass in 12/4/17... that's probably why it dropped....


ADXS insiders keep buying on monthly basis....

ADXS starting to recover, it would be hilarious if it closed green...

All of the day's suffering and frustration for nothing....

Deja Vu... my mind tells me that j read the exact same post in the month of December before... lol

"I guess we should just pack it in ....the world is coming to the end........hope for the worst......"

"I figure the cartel was responsible for about 7M out of the original 10M short"

The same 7M short number was/is also running through my mind....

I'm thinking the cartel is still holding strong to 7M where others (3M) realized it's best to cover considering limited $3 reward vs unlimited risk of shorting....

I'm also thinking the cartel is shorting it not to profit but to keep it down and more down.....

Take a deep breath and use logic....

Good or bad news doesn't matter: anyone would reasonably agree that a cancer treating company with 4 cancer franchises with $1 billion is partnership payments with phase 3 in SPA and Fast track should not be worth only as much as Cash on Hand.....

This is the time to buy more

200k volume in one hour is heavy volume for ADXS

ADXS down on heavy volume... could it be one of the tutes bailing out as tax loss sale?

Speaking of ADAGE, here's a nice paragraph from an old article dissing ADXS and ADAGE....

"The most recent spark which lit up the stock was an investment in December by Adage Capital, upping their stake to over $20 million in Advaxis. Retail investors therefore take the view that Adage has done deep due diligence and is making a concentrated bet on Advaxis. The reality is that Adage manages over $25 billion such that this position represents less than 0.001 of their holdings. The point is that what looks like a large position to retail investors is actually a miniscule position to Adage. The strategy that firms like Adage take is to hold numerous highly volatile small cap stocks based on a sector allocation (such as immuno-oncology) and then buy in at rock bottom prices. Some of them are bound to be doubles and triples just like Advaxis has already been since Adage last bought at $4.25."

Source:
https://www.google.ca/amp/s/seekingalpha.com/amp/article/2836026-advaxis-heavily-promoted-and-misleading-investors

What was that high volume yesterday and not much price fluctuations?

It seemed like some big guy offloading and another big guy loading just as much????

Volume is dead again today....

Fbg the reference you gave me yesterday also stated that ADXS is looking for Chief Medical Officer....

I wonder that is an attempt to hire someone above Petit? In addition to good scientists we need someone good with FDA processes...

Fears for women’s health as parents reject HPV vaccine

https://www.theguardian.com/society/2017/dec/03/hpv-vaccine-fears-women-health-take-up-falls?


HAVE NO FEAR, ADXS IS HERE!

Bob and Sara bough today.. as usual

If I were to guess, Very likely tax reform stuff...
A lot of good deductions are going to go away....

I'm glad you are able recover equal... a perfect example of how important diversification is....

In case of many including myself (probably you also), we are way more invested in ADXS because ADXS haS been ridiculously underpriced continually over the years...

This $3 price tops all of the past ridiculousness....

Can you please explain more Catdogg?

I'm interested in learning.

Ouch equal! Options are not cheap and I'm sure it's a bit hit on you...

I hope ADXS goes up soon! And it has every logical reason to do so...

Good reference thanks, it does mention change in strategy.

Now i don't me to drag it, but is that change referring to ADXS focusing on only "4 Franchises"?